Skip to main content
. 2018 May 4;9(34):23749–23760. doi: 10.18632/oncotarget.25255

Figure 2. Kaplan–Meier curves for overall survival (OS) according to the treatment dose of afatinib.

Figure 2

Patients receiving 40 mg and < 40 mg of afatinib during the first 6 months are represented by the red and blue lines, respectively.